Clarivate (NYSE:CLVT) Shares Down 5.2% – Here’s What Happened

Clarivate PLC (NYSE:CLVT)’s stock price fell 5.2% during trading on Monday . The company traded as low as $2.31 and last traded at $2.4560. Approximately 1,353,782 shares traded hands during trading, a decline of 80% from the average session volume of 6,680,027 shares. The stock had previously closed at $2.59.

Analyst Ratings Changes

A number of research firms have recently weighed in on CLVT. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $3.22.

Clarivate Stock Performance

The business’s fifty day moving average is $2.41 and its two-hundred day moving average is $2.58. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The stock has a market capitalization of $1.60 billion, a PE ratio of -11.83 and a beta of 1.38.

Clarivate (NYSE:CLVT) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. During the same quarter in the prior year, the firm earned $0.14 earnings per share. Clarivate’s revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, research analysts anticipate that Clarivate PLC will post 0.65 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. M&T Bank Corp bought a new stake in Clarivate during the fourth quarter worth approximately $34,000. PharVision Advisers LLC bought a new stake in shares of Clarivate in the 3rd quarter valued at approximately $45,000. Personal CFO Solutions LLC purchased a new position in shares of Clarivate in the 1st quarter worth approximately $30,000. FreeGulliver LLC purchased a new position in shares of Clarivate in the 1st quarter worth approximately $30,000. Finally, Pitcairn Co. bought a new position in shares of Clarivate during the 2nd quarter valued at approximately $52,000. Institutional investors own 85.72% of the company’s stock.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.